Skip to main content

Table 1 VTE incidence according to type of lymphoma

From: Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients

Lymphoma type VTE n (%)
Indolent NHL 9/170 (5.3%)
Aggressive NHL 49/415 (11.8%)
SLL 1/2 (50%)
Hodgkin lymphoma 10/119 (8.4%)
  1. Legend: VTE venous thromboembolism, NHL non-Hodgkin lymphoma, SLL small lymphocytic lymphoma